col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


17 Results       Page 1

 [1] 
Elsevier: Blood Reviews
  original article Date Title Authors   All Authors
1 [GO] 2024―Jun―03 Endothelial injury and dysfunction with emerging immunotherapies in multiple myeloma, the impact of COVID-19, and endothelial protection with a focus on the evolving role of defibrotide Clifton C. Mo, Edward Richardson, Eleonora Calabretta, Francesco Corrado, Mehmet H. Kocoglu, Rebecca M. Baron, et al. (+8)
2 [GO] 2023―Mar―28 Vaccinations in hematological patients in the era of target therapies: Lesson learnt from SARS-CoV-2 Bruno Fattizzo, Nicolò Rampi, Wilma Barcellini
3 [GO] 2022―Jul―31 Complement activation in COVID-19 and targeted therapeutic options: A scoping review Endry Hartono Taslim Lim, Rombout Benjamin Ezra van Amstel, Vieve Victoria de Boer, Lonneke Alette van Vught, Sanne de Bruin, Matthijs Christian Brouwer, et al. (+2)
4 [GO] 2022―Jun―12 SARS-CoV-2 vaccine safety and immunogenicity in patients with hematologic malignancies, transplantation, and cellular therapies Bin Ni, Ahmad Yanis, Kevin Dee, James D. Chappell, Daniel E. Dulek, Adetola A. Kassim, et al. (+3)
5 [GO] 2022―May―11 No apparent association between mRNA COVID-19 vaccination and venous thromboembolism Matthew Nicholson, Hadi Goubran, Noel Chan, Deborah Siegal
6 [GO] 2022―Jan―31 COVID-19 breakthrough infections, hospitalizations and mortality in fully vaccinated patients with hematologic malignancies: A clarion call for maintaining mitigation and ramping-up research Lindsey Wang, David C. Kaelber, Rong Xu, Nathan A. Berger
7 [GO] 2021―Nov―20 Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature Wouter S. Hoogenboom, Tharun T. Alamuri, Daniel M. McMahon, Nino Balanchivadze, Vrushali Dabak, William B. Mitchell, et al. (+3)
8 [GO] 2021―Sep―04 Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues Robert J. Kreitman, Evgeny Arons
9 [GO] 2020―Dec―08 The impact of ABO blood group on COVID-19 infection risk and mortality: A systematic review and meta-analysis Nanyang Liu, Tingting Zhang, Lina Ma, Huiqing Zhang, Huichan Wang, Wei Wei, et al. (+2)
10 [GO] 2020―Nov―09 When hematologic malignancies meet COVID-19 in the United States: Infections, death and disparities QuanQiu Wang, Nathan A. Berger, Rong Xu
11 [GO] 2020―Nov―08 A review on how to do hematology consults during COVID-19 pandemic Kamal Kant Sahu, Jan Cerny
12 [GO] 2020―Oct―08 Coagulation and anticoagulation in COVID-19 Tarik Hadid, Zyad Kafri, Ayad Al-Katib
13 [GO] 2020―Aug―24 Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system Maria Grazia Lazzaroni, Silvia Piantoni, Stefania Masneri, Emirena Garrafa, Giuliana Martini, Angela Tincani, et al. (+2)
14 [GO] 2020―Aug―18 The looming storm: Blood and cytokines in COVID-19 Supreet Kaur, Rashika Bansal, Sudarsan Kollimuttathuillam, Anusha Manje Gowda, Balraj Singh, Dhruv Mehta, Michael Maroules
15 [GO] 2020―Aug―13 Promising role for mesenchymal stromal cells in coronavirus infectious disease-19 (COVID-19)-related severe acute respiratory syndrome? Hamdan Hamdan, Shahrukh K. Hashmi, Hillard Lazarus, Robert Peter Gale, Wenchun Qu, Riad El Fakih
16 [GO] 2020―Jul―04 Understanding the andromeda strain - The role of cytokine release, coagulopathy and antithrombin III in SARS-CoV2 critical illness Nabiel Mir, Alex D'Amico, John Dasher, Ashita Tolwani, Vincent Valentine
17 [GO] 2020―May―15 Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes James T. England, Alym Abdulla, Catherine M. Biggs, Agnes Y.Y. Lee, Kevin A. Hay, Ryan L. Hoiland, et al. (+5)
 [1] 

17 Results       Page 1



[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec